Cramer’s lightning round: Stay with Vertex Pharmaceuticals

Cramer’s lightning round: Stay with Vertex Pharmaceuticals


Getty Images Holdings Inc: “I think down here at $4, I’m not a SPAC guy, okay, but this one may be actually worth looking at.”

Cramer's lightning round: Stay with Vertex Pharmaceuticals

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

Walmart will report earnings before the bell. Here’s what to expect
Business

Walmart will report earnings before the bell. Here’s what to expect

The logos of Walmart and Sam’s Club are pictured in Cuautitlan Izcalli, Mexico, January 30, 2025. Raquel Cunha | Reuters Walmart will report quarterly earnings on Thursday, as economists and investors try to gauge how U.S. consumers are responding to President Donald Trump’s decision to raise tariffs on dozens of countries across the globe. Here’s […]

Read More
As Target chases a comeback, its new CEO must take on skeptical investors and customers
Business

As Target chases a comeback, its new CEO must take on skeptical investors and customers

People walk by a Target store in midtown Manhattan in New York City, March 21, 2025. Kylie Cooper | Reuters When Target’s new CEO Michael Fiddelke steps into the role in early February, he will inherit a company facing slumping sales, faltering customer loyalty and skeptical investors. Its fiscal second-quarter results posted Wednesday illustrated the […]

Read More
How hurricane resilience for commercial real estate is leveraging drones and AI
Business

How hurricane resilience for commercial real estate is leveraging drones and AI

A screenshot of Site Technologies’ commercial real estate risk assessment tools. Courtesy of Site Technologies A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors […]

Read More